Show simple item record

dc.contributor.advisorBlessley, Misty P.
dc.creatorSantomauro, Joanne DeFusco
dc.date.accessioned2020-10-16T14:08:49Z
dc.date.available2020-10-16T14:08:49Z
dc.date.issued2019
dc.identifier.urihttp://hdl.handle.net/20.500.12613/560
dc.description.abstractUntil recently, academic and practitioner research on clinical trial supply chains focused on identifying innovative models and solutions in providing comparator and study drugs to global clinical sites. Due to the expansion of outsourcing efforts by pharmaceutical organizations, newly enacted global laws and regulations, and the continued push to increase the speed at which new drugs gain market approval, a new and extremely complex global “ancillary” supply chain has emerged. This manuscript focuses on the clinical trial ancillary supply chain: a supply chain that develops the end-to-end process resulting in the distribution and quality management of medical products and devices, consumable supplies, and patient giveaways to global clinical trial sites. Based on a series of quantitative analyses, this research assesses the influence of the customer, country, and product on the overall success of the supply chain. Three factors emerged from these analyses as having a direct influence on the clinical trial ancillary supply chain; product characteristics, magnitude (components of size), and stability (components of changes in scope). Part II of this research sought to understand the success of the supply chain by evaluating the moderating effects of knowledge management, organizational culture, therapeutic area, and type of shipment. Assessments of 444 customer and server surveys yielded components of a sense of shared culture, shared communication and transparency, and feeling educated and supported. Quantitative data analysis supported that these components had a moderating influence on success during the pre-trial phase of the supply chain. These research findings provide insight into the internal and external drivers of success within the complex and emergent clinical trial supply chain – a supply chain that helps pharmaceutical organizations bring innovative therapies to market and most important, those patients in need of such therapies to improve or even save their lives.
dc.format.extent124 pages
dc.language.isoeng
dc.publisherTemple University. Libraries
dc.relation.ispartofTheses and Dissertations
dc.rightsIN COPYRIGHT- This Rights Statement can be used for an Item that is in copyright. Using this statement implies that the organization making this Item available has determined that the Item is in copyright and either is the rights-holder, has obtained permission from the rights-holder(s) to make their Work(s) available, or makes the Item available under an exception or limitation to copyright (including Fair Use) that entitles it to make the Item available.
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectBusiness Administration
dc.subjectAncillary Supply Chains
dc.subjectClinical Trial Supply Chains
dc.subjectKnowledge Management
dc.subjectOrganizational Culture
dc.subjectSupply Chain Success
dc.titleAn Exploration of the Global Clinical Trial Ancillary Supply Chain and the Drivers of Success During the Pre, In, and Post Phases
dc.typeText
dc.type.genreThesis/Dissertation
dc.contributor.committeememberDi Benedetto, C. Anthony
dc.contributor.committeememberRosenthal, Edward C., 1959-
dc.contributor.committeememberAndersson, Lynne Mary
dc.description.departmentBusiness Administration/Interdisciplinary
dc.relation.doihttp://dx.doi.org/10.34944/dspace/542
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.degreeD.B.A.
refterms.dateFOA2020-10-16T14:08:49Z
dc.embargo.lift05/17/2021


Files in this item

Thumbnail
Name:
TETDEDXSantomauro-temple-0225E ...
Size:
661.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record